Evaluation of an Asynchronous Remote Communities Approach to Behavioral Activation for Depressed Adolescents
2 other identifiers
interventional
70
0 countries
N/A
Brief Summary
The goal of this clinical trial is to learn if a digital health intervention, called "ActivaTeen," improves depression treatment for teenagers with depression. The investigators also want to know if ActivaTeen is easy to use for both teenagers and mental health clinicians who help deliver treatment through ActivaTeen. All teenagers in the study will receive an individual depression therapy called Behavioral Activation or "BA" and about half will also use ActivaTeen. The main questions this trial aims to answer are:
- Does ActivaTeen improve depression treatment for teenagers?
- Do teenagers and clinicians find ActivaTeen to be acceptable? Researchers will compare teenagers using ActivaTeen along with BA to teenagers who are only doing BA to see the effects of ActivaTeen. Participants in the study will:
- Fill out surveys online several times during the study, which lasts about 6 months
- Receive individual BA therapy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable depression
Started Apr 2025
Shorter than P25 for not_applicable depression
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 20, 2024
CompletedFirst Posted
Study publicly available on registry
January 22, 2025
CompletedStudy Start
First participant enrolled
April 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedJanuary 22, 2025
January 1, 2025
11 months
December 20, 2024
January 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Intervention Usability Scale
The IUS was adapted from the System Usability Scale, with the word "system" replaced with "intervention platform" for each item. Items are rated on a Likert-type scale from 0 (strongly disagree) to 4 (strongly agree) and half of the items are reverse-scored. The total score is calculated by multiplying the sum of these scores by 2.5 (possible range: 0-100), with higher scores indicating greater usability.
Week 12
User Burden Scale
The User Burden Scale (UBS) is a widely used and reliable scale that includes 20-items that capture user burden of computing systems across 6 subscales1) difficulty of use, 2) physical, 3) time and social, 4) mental and emotional, 5) privacy, and 6) financial. Items are rated on a 5-point Likert scale from 0 (Never/Not at all) to 4 (All of the time/Extremely). Higher scale scores indicate greater user burden.
Week 12
Client Satisfaction Questionnaire - 8
The CSQ-8 is an 8-item, unidimensional measure assessing general satisfaction with mental health services. Higher scores indicate greater satisfaction (range: 8 - 32)
Week 12
Acceptability Of Intervention Measure
The Acceptability of Intervention Measure assesses the acceptability of a particular intervention. The measure has 4 items each and responses are coded on a 1 - 5 Likert scale (Completely Disagree to Completely Agree). Higher scores indicate greater acceptability (range: 4 - 20)
Week 12
Intervention Appropriateness Measure
The Intervention Appropriateness Measure assesses the appropriateness of a particular intervention. The measure has 4 items each and responses are coded on a 1 - 5 Likert scale (Completely Disagree to Completely Agree). Higher scores indicate greater appropriateness (range: 4 - 20)
Week 12
Feasibility Of Intervention Measure
The Feasibility of Intervention Measure assesses the feasibility of a particular intervention. The measure has 4 items each and responses are coded on a 1 - 5 Likert scale (Completely Disagree to Completely Agree). Higher scores indicate greater feasibility (range: 4 - 20)
Week 12
Secondary Outcomes (2)
Loneliness
Baseline to Week 24
Therapeutic Alliance
Week 12
Other Outcomes (14)
Enrollment Rate
Baseline
Loss to Follow Up Rate
Baseline to Week 24
Behavioral Activation Attendance
Baseline to Week 12
- +11 more other outcomes
Study Arms (2)
ActivaTeen + BA
EXPERIMENTALReceives access to ActivaTeen app along with individual behavioral activation therapy
BA Only
ACTIVE COMPARATORReceives individual behavioral activation therapy alone
Interventions
The ActivaTeen app is built on HIPAA-compliant instance of a popular messaging software. Participants in the treatment group can access the app at any time via desktop or mobile, where they can find features designed to enhance their receipt of BA therapy. These features include: weekly BA skills and homework completion support, in-app messaging with their BA therapist, mood and activity tracking and data visualizations, chatbot check-ins on progress and guided problem-solving around barriers, and moderated peer support using the ActivaTeen app. The app will have a moderator, who is part of the study team, to manage peer-to-peer interactions within ActivaTeen.
Behavioral activation therapy involves individual weekly sessions with a trained therapist for 12 weeks. The sessions are completed either in-person or via telehealth. The treatment focuses on behavioral manifestations of depression such as isolating, and how these behaviors are interconnected with low mood and depressive emotions. BA helps patients find ways to engage in behaviors that are meaningful to them based on their values, priorities, and goals, with the aim of creating positive loops between doing meaningful activities and improved mood. The therapist provides structure and problem-solving for activating these behaviors and keeping track of changes over time.
Eligibility Criteria
You may qualify if:
- Age 13 - 19
- Referred for MDD treatment
- Clinically assessed diagnosis of current MDD based on caregiver or patient report or a PHQ-8 total of 8 or greater (moderate MDD)
- MDD clinically determined to be the primary diagnosis
- English-speaking
- Access to a smartphone device
You may not qualify if:
- Developmental disability (e.g., intellectual disability, autism spectrum disorder)
- Severe psychiatric comorbidity (e.g., active suicidality requiring higher level of care; psychosis or substance use, bipolar, or conduct disorder)
- Previously completed a full course of evidence based psychosocial intervention for depression
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jessica Jenness, PhD
University of Washington
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor: Department of Psychiatry and Behavioral Sciences
Study Record Dates
First Submitted
December 20, 2024
First Posted
January 22, 2025
Study Start
April 1, 2025
Primary Completion
March 1, 2026
Study Completion
March 1, 2026
Last Updated
January 22, 2025
Record last verified: 2025-01